HI
HAE icon

Harbour Investments’s Haemonetics HAE Stock Holding History

Harbour Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25
Closed -$1.86K – 3796
2025
Q2 		$1.86K Hold
25
– – ﹤0.01% 3153
2025
Q1 		$1.59K Sell
25
-35
-58% -$2.38K ﹤0.01% 3138
2024
Q4 		$4.68K Buy
60
+35
+140% +$2.81K ﹤0.01% 2748
2024
Q3 		$2.01K Hold
25
– – ﹤0.01% 2923
2024
Q2 		$2.07K Sell
25
-25
-50% -$2.2K ﹤0.01% 2800
2024
Q1 		$4.27K Hold
50
– – ﹤0.01% 2555
2023
Q4 		$4.28K Hold
50
– – ﹤0.01% 2471
2023
Q3 		$4.48K Hold
50
– – ﹤0.01% 2308
2023
Q2 		$4.26K Hold
50
– – ﹤0.01% 2330
2023
Q1 		$4.14K Hold
50
– – ﹤0.01% 2340
2022
Q4 		$3.93K Buy
+50
New +$4.02K ﹤0.01% 2295

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harbour Investments's HAE Position: Q3 2025 in Review

Harbour Investments sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 25 shares — an estimated $1.86K sold.

Harbour Investments first reported a position in HAE in Q4 2022 and held it in 11 quarters. The position peaked at $4.68K in Q4 2024. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Harbour Investments reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Harbour Investments sold 25 Haemonetics shares in Q3 2025, an estimated $1.86K.
  • Harbour Investments first reported a position in Haemonetics in Q4 2022 and held it in 11 quarters.
  • Harbour Investments's Haemonetics position peaked at $4.68K in Q4 2024.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Harbour Investments's 13F filing for Q3 2025, filed 12 Nov 2025.